Position in MRNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$37,519,761
+$22,951,318 QoQ
Shares Held
738,578
+49.5% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,300,473,279 across 256 Biotechnology names. MRNA ranks #63 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $37,519,761 | 738,578 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $14,568,443 | 494,013 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $12,472,402 | 482,865 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $17,220,546 | 624,159 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $18,227,574 | 642,948 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $44,617,626 | 1,073,055 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $97,570,396 | 1,459,979 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $189,967,699 | 1,599,728 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $108,605,631 | 1,019,197 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $110,140,377 | 1,107,495 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $154,422,474 | 1,495,038 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $145,974,231 | 1,201,434 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $247,640,224 | 1,612,451 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $490,183,518 | 2,729,003 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $761,933,113 | 6,443,409 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $484,600,625 | 3,392,374 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $416,600,646 | 2,418,441 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $617,630,595 | 2,431,808 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $938,323,317 | 2,438,090 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $522,260,673 | 2,222,575 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $306,147,350 | 2,337,895 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $140,482,898 | 1,344,720 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $69,938,992 | 988,537 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $65,292,580 | 1,016,860 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $15,743,007 | 525,643 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||